Solventum Co. (NYSE:SOLV) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Solventum Co. (NYSE:SOLV) have been assigned an average recommendation of “Hold” from the ten brokerages that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $68.00.

Several research firms have issued reports on SOLV. The Goldman Sachs Group lifted their price target on shares of Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a report on Monday, August 12th. Wells Fargo & Company dropped their target price on Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a report on Friday, August 9th. BTIG Research assumed coverage on shares of Solventum in a research note on Thursday, September 5th. They issued a “neutral” rating for the company. Piper Sandler upped their price target on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Finally, Morgan Stanley upped their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th.

Institutional Investors Weigh In On Solventum

A number of institutional investors have recently modified their holdings of the company. Davis Selected Advisers purchased a new stake in Solventum during the 2nd quarter worth approximately $273,070,000. Nuance Investments LLC acquired a new position in shares of Solventum in the second quarter worth $115,829,000. Newport Trust Company LLC purchased a new stake in shares of Solventum during the second quarter worth $98,976,000. Baupost Group LLC MA acquired a new stake in shares of Solventum in the second quarter valued at $96,242,000. Finally, Hotchkis & Wiley Capital Management LLC purchased a new position in Solventum in the third quarter valued at $125,488,000.

Solventum Trading Up 1.1 %

Shares of SOLV opened at $71.58 on Thursday. The company has a 50 day moving average price of $70.52 and a 200-day moving average price of $62.35. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum has a fifty-two week low of $47.16 and a fifty-two week high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.